Agent for preventing or treating hemorrhage tendency

Details Agent for preventing or treating hemorrhage tendency Agent for preventing or treating hemorrhage tendency

A - Human Necessities

61

K

A61K 38/20 (2006.01) C07K 14/54 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2098008

ABSTRACT An agent for preventing or treating hemorrhage tendency comprising IL-6 as an active ingredient is presented. The in vivo administration of IL-6 enhances both platelet function and vascular endothelial cell function, to improve predispositions to bleeding disorder, thereby promoting hemostatic ability. That is, IL-6 has activity to efficiently treat hemorrhage tendency in vivo, and since it is an inherently natural bioactive substance, it is useful as an excellent phermaceutical composition for treating or preventing hemorrhage tendency. Thus, IL-6 is useful for treating the hemorrhage tendency attributable to the bone marrow supression occurring after the chemotherapy of cancer or after the radiotherapy of cancer, the hemorrhage tendency occurring after bone marrow transplantation, the hemorrhage tendency of aplastic anemia, and the hemorrhage tendency in idiopathic thrombocytopenic purpura.

Affiliated with

Also associated with

Rating

Agent for preventing or treating hemorrhage tendency does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for preventing or treating hemorrhage tendency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for preventing or treating hemorrhage tendency will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1654831